• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10 Orthopedic Device Firms
    • Buyers' Guide
    • Events
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10 Orthopedic Device Firms
  • Buyers' Guide
  • Events
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    Top Features
    From Nitinol to Nanotubes: A Materials Science Roundtable

    In Good Repair: Trauma Technologies Under Review

    Anxious Undertones: A Review of 2019

    Automated Analysis Advantages for Part Validation

    Tried and True Metalworking
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Orthofix Appoints New Spine Business Leader

    Viant to Halt EtO Sterilization at Michigan Plant by End of Year

    Synaptive Medical's Modus V Expands Into Spine Market

    3D-Printed Graftless Bone Transplants Go to Clinical Trials

    CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    3D-Printed Graftless Bone Transplants Go to Clinical Trials

    CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers

    Micro Spine Implant Could Restore Standing and Walking

    RTI Surgical Appoints New Division Leaders

    From Nitinol to Nanotubes: A Materials Science Roundtable
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Molybdenum-Rhenium Biomaterial: Something ‘MoRe’?

    New Exoskeleton Shoulders Rehab Burden for Stroke Patients

    Repairing Knee Cartilage Defects with the Patient's Own Cells

    Compamed 2019 Preview Report

    Straightening Out a Spinal Device’s De Novo Pathway
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Donatelle

    Orchid Orthopedic Solutions

    NN Life Sciences

    Hammill Medical

    Nelson Laboratories LLC
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10 Orthopedic Device Firms
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Features

    Making the Grade: A Testing and Analysis Roundtable

    This roundtable discussion examines the technological and regulatory factors affecting the third-party testing and analysis services industry.

    Making the Grade: A Testing and Analysis Roundtable
    Testing methods and equipment continue to be optimized for new devices. Image courtesy of Element.
    Related CONTENT
    • Why Big Companies With Internal Labs Should Outsource Testing
    • Pain Control Technology Embraces the Challenge to Reduce or Eliminate Opioids
    • Tiny Bioelectronic Implant Eases the Pain of Rheumatoid Arthritis
    • Remote-Controlled Pain Management Puts the Patient in Charge
    • Wearable Over-the-Counter TENS Device Treats Pain in Bed and On the Go
    Sam Brusco, Associate Editor09.17.19
    Medical and orthopedic devices are becoming smaller and more complex. Manufacturing technologies are advancing, new materials are frequently being created, and regulations are becoming more stringent. All of these factors working in concert have ensured a healthy medical device testing and analysis market—one that Research and Markets forecasts to reach $13.4 billion by 2025 with a CAGR of 11.5 percent.

    Orthopedic products have more to examine than ever before. Regulatory bodies expect polymeric materials to be screened for low molecular weight impurities and additives like residual monomers and solvents, light stabilizers, and antioxidants. For 510(k) submissions, the U.S. Food and Drug Administration (FDA) demands more detailed material compatibility and device cleaning studies. Testing isn’t limited to the device themselves either—packaging is subject to increased scrutiny, including usability and environmental impact.

    The regulatory landscape will prove particularly challenging for medical and orthopedic device manufacturers looking to have products tested and analyzed, as both the EU and FDA will be modifying their standards in the near future. The May 2020 EU MDR deadline looms ever closer, and will promote a lifecycle approach to medical device regulation, as opposed to the previous MDD’s more significant focus on the pre-approval stage of medical device manufacturing. The FDA has also made several recent announcements declaring a planned review of its 510(k) submission process, which may call for more detailed testing and analysis.

    In order to gain more insight on testing and analysis services for the orthopedic and medical device industries, ODT spoke to the following experts:

    Maciej Jakucki, medical device manager at Element Materials Technology, a Fairfield, Ohio-based global provider of testing, inspection, and certification services for a diverse range of materials and products.

    Matthew Jorgensen, senior extractables and leachables expert at Nelson Laboratories, a Sotera Health company based in Salt Lake City that provides full lifecycle microbiology testing services for the medical device, pharmaceutical, tissue, and natural products industries.

    Dawn Lissy, president of Empirical Testing Corporation, a Colorado Springs, Colo.-based provider of mechanical testing for medical devices.

    Christopher Parker, associate department head, in-vivo biocompatibility at Toxikon Corporation, a Bedford, Mass.-based preclinical contract research organization providing in vivo, in-vitro, and analytical testing services for the pharmaceutical, biotechnology, and medical device industries.

    Rudy Pina, president of Dynatec Scientific Labs, an El Paso, Texas-based medical device testing laboratory.

    Thor Rollins, director of toxicology and extractables and leachables consulting for Nelson Laboratories.

    Christopher Scott, vice president of Eurofins Medical Device Testing, a Lancaster, Pa.-based international laboratory services company that provides a broad range of testing capabilities to the medical device industry.

    Don Tumminelli, senior technical manager, client services, at HIGHPOWER Validation Testing & Lab Services, a Rochester, N.Y.-based provider of reusable medical device cleaning, packaging, and sterilization validation services.

    Sam Brusco: Has your business been experiencing a rise in any particular testing methodologies? If so, why?
    Maciej Jakucki:
    With the positive growth experienced in the extremities market, companies are exploring multi-axis methodologies where several different loads can be applied to a test setup instead of just axial or torsional loads. Shoulder, ankles, elbows, and wrists are complex joints that require thinking outside of the box, particularly if a unique design component is featured. Many of these tests borrow from methodologies of more well-established joints like hip and knee, but need to be modified and aligned to physiological loading. This has been an area of significant growth and our ability to partner with the customer and design custom methods continually adds to our expertise. Another growing area is evaluating wear debris, which can range from intentionally introducing media into the test chambers in order to accelerate wear (3rd body wear testing) or simply quantifying the morphology of particulate generated during a fatigue or corrosion test.

    Matthew Jorgensen: There has been a sharp increase in evaluations of biological endpoints leveraging analytical data instead of traditional biological testing. For example, gas path device testing per ISO 18562 has started to become mainstream and is rising sharply as manufacturers of devices within this class prepare for the MDR.

    Dawn Lissy: We are seeing a rise in new and updated versions of older technologies—for example, trauma plates, screws, IM nails, etc.

    Christopher Parker: When ISO 10993-1 was published in 2018, which was predicated by FDA’s Use of ISO 10993-1 document in 2016, there was an increased requirement for chemical and physical characterization, and we’ve seen a big rise in the needs for analytical chemical characterization with associated toxicological risk assessments. In general, the need for risk based evaluations, both biological and toxicological, has increased as ISO 14971 and ISO 10993-1 have moved in that direction.

    Rudy Pina: An increase has been noted in cleanroom services such as design, certification, and implementation due to the movement of U.S. companies to other countries. The reason for this movement is unknown to Dynatec.

    Thor Rollins: Yes, extractable and leachable (E&L) testing. There are two main reasons behind the rise in demand, MDR and the new ISO 10993-1. In the new version of ISO 10993-1, we added a requirement to gather material or chemical information for every medical device. This doesn’t necessarily mean every device needs full E&L, but should be based on risk of the device and previous knowledge from the materials and process. For high risk devices, this tends to mean that E&L testing is needed to fully address the risk of the device. The other reason is the new MDR in May 2020—all devices need to be reevaluated to the current standard, so a lot of devices currently in the EU market don’t have the chemistry data and there is a scramble for labs to try to get this information before they have to submit to a Notified Body.

    Christopher Scott: We have seen an increased demand for chemical characterizations, as our clients are responding to the changes in ISO 10993 standard, which mandate this testing as a precursor to in vitro and in vivo elements of biocompatibility testing.

    Don Tumminelli: Yes, cleaning validations for reusable devices have been increasing due to the increased scrutiny of FDA and regulatory agencies around the globe enforcing that cleaning instructions for use (IFUs) are validated. This increased scrutiny comes after multiple superbug outbreaks resulting from inadequately cleaned devices.

    Brusco: Which technological advancements/new equipment offerings have most impacted your testing services business?
    Jakucki:
    The continued and growing use of additive manufacturing is driving a significant amount of testing for the medical device industry. Companies are concerned about build plate variation, consistent performance, and validation during both the R&D and production phases. The necessary testing includes powder characterization, material evaluation of the printed material through tensile, chemistry and metallography, and product level testing that simulates physiological conditions. With unique geometries like expandable spine cages or other trabecular type structures, trying to predict failure can be a challenge. Overall, manufacturers are asking more questions about material performance and really trying to understand the mechanical behavior—much more so than in the past.

    Jorgensen: The key advancements have been related to analytical chemistry. Highly specialized methods that have been more traditionally found in academic research laboratories are now being applied routinely in medical device chemistry studies. A good example of this is liquid chromatography with high-resolution accurate mass detection, which can measure the mass of an unknown compound to several decimal places. Measuring compound mass with this precision allows determination of an unknown compound’s empirical formula, which is a great aid in identification.

    Lissy: Mechanical test frames are pretty constant; there are relatively little or new equipment or advancements in this regard.

    Pina: Robotics seems to have made a significant impact on the specialized side of manufacturing.

    Scott: Advancements in alternative in vitro biocompatibility methods represent an exciting area for our industry, as there is a widely embraced motivation to reduce our dependency on in vivo testing. Although there will be some time before this data will be accepted in lieu of animal testing, we see clients opting to pursue these methods for early stage feasibility work.

    Tumminelli: The increased use of low-temperature sterilization, due to more complicated devices that cannot be processed through steam sterilizers. 

    Brusco: How have recent regulatory activities impacted your testing services business?
    Jakucki:
    The dominant trend right now is MDR and the upcoming May 2020 deadlines for compliance. It has definitely resulted in an increase in testing as companies align with MDR and bring their current product lifecycles in line. This has also resulted in additional pressure to support their efforts in areas like protocol development and general supply chain management. One of the interesting areas that has had a positive impact is the increased pressure on post market surveillance. Customers are asking more questions about safety, implementing failure analysis on failed parts and instruments to tie back to trends, and performing functional testing to replicate clinical failure modes. We have seen an increase in requests for autoclave and durability testing on instrumentation as well as component insertion/removal test programs.

    Jorgensen: The FDA is in a period of transition with respect to what they will and will not accept regarding some of the details of chemistry testing. This transition has resulted in a currently moving target with regards to testing expectations.

    Lissy: It seems the EU MDR activities are impacting R&D and product development efforts, in that engineers are being pulled off these projects and working on what is needed to meet the May 2020 implementation deadline.

    Parker: With the MDR regulations having various time points coming due over the next few years, there has been an increased need for biocompatibility, chemical characterization, risk assessments, gap assessments, and biological evaluations as manufacturers rush to complete their evaluation—or re-evaluation—programs in time.

    Pina: There was a slight drop in services, specifically those services related to import/export via Mexico. The drop was short-lived, since the negotiations for the NAFTA agreement appear to have been resolved by all parties involved.

    Rollins: As mentioned previously, the MDR is a big impact. Since a lot of older devices have not been kept up to the current standards, each device has to go through a gap analysis to the current requirements and then brought up to standard before getting a new CE mark. 

    Scott: The new MDR in Europe has created a surge in demand for testing services, as manufacturers seek to complete their technical dossiers prior to the spring 2020 transition deadline.

    Tumminelli: The revamped MDR and FDA guidance document for reprocessing have both increased the responsibility of the device manufacturer to validate their IFUs and provide objective evidence of such. In the EU, internal disinfection is being enforced using the A0 method of thermal disinfection to demonstrate the device is safe for reprocessing personnel. In the U.S., cleaning is being enforced to include simulated use testing and increased sample size.

    Brusco: What changes in testing protocol do you foresee based on FDA’s planned update of the 510(k) program?
    Scott:
    The FDA has made their expectations fairly clear that the cybersecurity of electronic devices must be addressed. This is one of the most dynamic aspects of our business, as digital technologies permeate the medical device industry, and manufacturers face a new element of risk in their design control process.

    Tumminelli: This is yet to be seen. We do not predict increases in volume of testing, but rather decreases in FDA response in regards to test protocols.

    Brusco: If applicable to your business, how is continued rise of the use of additive manufacturing impacting your testing protocols?
    Jakucki:
    Testing protocols are becoming more complex with additional requirements for inspection and post-test analysis. Identifying a fracture in a complex geometry may be next to impossible, as they may not be visible to the naked eye or under a 10x magnification. One of the telltale signs is debris generation, but that also may not always be clear for a complex structure. Technologies such as CT scanning can help evaluate the post-test devices, but there is a cost/benefit analysis that must be considered. As mentioned previously, size and shape analysis of debris is common, coupled alongside ion or metal content analysis in the fluid. In some parts of our medical testing business—cardiovascular for example—we are performing nickel ion leaching tests to evaluate whether there are elevated ion levels during testing. On the materials side, build directions need to be considered. A tensile test on a cast or forged device used to be sufficient. With additive, multiple orientations at different locations are routinely taken to confirm performance in the build plate. A level of complexity has been introduced in terms of keeping track of not just performance, but performance related to where the device is printed. Another area critical for additive is the chemical composition. As the materials are exposed to heat during the builds, re-use powder, or go through post processing, it can be a challenge to ensure the chemical compositions meet the target acceptance criteria, particularly around oxygen content. This has impacted our processes and specimen preparation, making sure testing process variability is minimized. Essentially, what used to be routine testing is no longer as routine due to the potential variability of the printing process.

    Jorgensen: Additive manufacturing often involves novel materials that have limited existing toxicological information, and the hallmark of these devices is they are infinitely able to be personalized. Handling these devices requires great care in designing a representative test article, and extra rigor in testing due to regulatory skepticism of novel materials. We often partner with additive device manufacturers very early in the product development process to try and avoid heartburn down the road when it comes to testing for actual FDA submission.

    Lissy: Additive manufactured devices are changing the landscape of the orthopedic industry. From a mechanical testing standpoint, some changes have to be made for the testing to accommodate these types of devices, but to date, the acceptance criteria and overall methodology has not changed. Patient-specific devices, through AM devices, will impact how we determine and test worst-case implants for a family of devices.

    Parker: In the world of biocompatibility, we work with a fixed set of methods and testing programs are built with the specific devices in mind. Additive manufactured devices are assessed like any other device with the same contact type and duration. One of the unique advantages of these devices is that once a base material and manufacturing process has been evaluated for biocompatibility, a cranial plate is no different than a plate used for a leg fracture as long as surface characteristics and other physical properties have been risk assessed appropriately.

    Rollins: The main impact comes from new and novel types of chemicals to the medical device industry. For years, most devices were made from the same materials using the same processing, but with additive manufacturing, we see new materials, new process residuals, or both. This creates a challenge to predict safety from chemicals that don’t contain sufficient toxicological information.

    Scott: 3D printing has allowed us to fabricate custom test fixtures more quickly than traditional manufacturing techniques, thus improving turnaround time for our testing services. 

    Brusco: How do you see orthopedic/medical device testing services and equipment progressing in the coming years?
    Jakucki:
    Uniaxial testing will continue to serve its purposes, but there has been a trend toward multi-axis testing to try to evaluate more relevant failure mechanisms. Traditional equipment will continue to evolve as standardization catches up, but there is definitely more interest in multi-axis evaluation. As technology continues to improve, FEA simulation and validation will really start transforming design and the overall testing process. From a materials perspective, the industry still primarily relies on titanium, cobalt chrome, and stainless steel. While there has been progress in the use of combined nonmetallic and traditional materials, it is a matter of time before new materials start transforming the medical space.

    Parker: In biocompatibility, there will be a continued effort to create validated in-vitro alternatives to various animal tests. Currently underway in various biocompatibility documents are alternatives to irritation, sensitization, and pyrogenicity tests, although their acceptance by various regulatory bodies may vary.

    Rollins: We see more and more pressure away from animal testing and more to alternative methods. This change is impacting both the standards and the regulatory authorities. 

    Brusco: Is there anything else you’d like to say regarding orthopedic/medical device testing trends and challenges?
    Jakucki:
    Another trend we have observed is an increase in feasibility testing—testing multiple configurations prior to a final design or submission. With additive specifically, companies can create unique geometries at relatively low cost, but may not be sure which direction to take or which device iterations align with their acceptance criteria. Changes in printing parameters or process changes can also have a major impact on the performance of these devices. As such, feasibility testing allows quick evaluations to help decide the best direction. While additive has provided many benefits, challenges around patient-specific solutions and personalized medicine have increased. Trying to identify worst-case or regulatory risk on unique implants, minimal material conditions, and software integration have led to additional validation requirements.

    Lissy: If patient-specific devices take off in applications beyond maxial-facial applications, more testing and scrutiny will occur.

    Scott: We see increased scrutiny by regulators on data integrity and Part 11 compliance. As the testing industry generates more digital data and manages that data with electronic laboratory notebooks and LIMS systems, ensuring data integrity compliance has become a critical operational requirement. As a result, we are hiring more IT specialists who work alongside our chemists, microbiologists, and engineers to review electronic data audit trails and maintain data security.

    Tumminelli: There will be a larger demand for low-temperature processes. As devices become more complex, a need for new sterilization technologies will be needed. Additionally, for industrial sterilization, ethylene oxide is being questioned regarding residuals and emissions, which is spurring the industry to look for ways to minimize the use of ETO and bring residuals and emissions to near-zero levels. It is inevitable to look for alternative processes as part of the solution. 
    Related Searches
    • extremities
    • regulations
    • iso
    • implants
    Suggested For You
    U.S. May Offer a Safe Harbor from the Impending MDR Storm U.S. May Offer a Safe Harbor from the Impending MDR Storm
    Hidden Gems: 6 Orthopedic Technology Innovators of Note Hidden Gems: 6 Orthopedic Technology Innovators of Note
    Connecting the Dots in Medical Device Outsourcing Connecting the Dots in Medical Device Outsourcing
    Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry Mayday: How the Upcoming MDR Implementation Forecasts Disaster for Our Industry
    Sterigenics,  A Sotera Health company Sterigenics, A Sotera Health company
    Toxikon Corporation Toxikon Corporation
    Nelson Laboratories LLC Nelson Laboratories LLC
    What’s ‘In’ for Manufacturing? (Hint: It’s Not Neon) What’s ‘In’ for Manufacturing? (Hint: It’s Not Neon)
    ODT Forum Program Notebook ODT Forum Program Notebook
    Wearable Over-the-Counter TENS Device Treats Pain in Bed and On the Go Wearable Over-the-Counter TENS Device Treats Pain in Bed and On the Go
    Remote-Controlled Pain Management Puts the Patient in Charge Remote-Controlled Pain Management Puts the Patient in Charge
    Tiny Bioelectronic Implant Eases the Pain of Rheumatoid Arthritis Tiny Bioelectronic Implant Eases the Pain of Rheumatoid Arthritis
    Pain Control Technology Embraces the Challenge to Reduce or Eliminate Opioids Pain Control Technology Embraces the Challenge to Reduce or Eliminate Opioids
    Why Big Companies With Internal Labs Should Outsource Testing Why Big Companies With Internal Labs Should Outsource Testing

    Related Features

    • 3-D Printing/Additive Mfg. | Machining & Tooling | Materials | Molding
      From Nitinol to Nanotubes: A Materials Science Roundtable

      From Nitinol to Nanotubes: A Materials Science Roundtable

      While new materials are being made available, orthopedic device makers still lean on the well-established options for most new development.
      Mark Crawford, Contributing Writer 12.02.19

    • Biologics | Spine/Neurology | Trauma/Sports
      In Good Repair: Trauma Technologies Under Review

      In Good Repair: Trauma Technologies Under Review

      Novel technologies offer new approaches to fixing traumatic injuries when accidents happen.
      Sam Brusco, Associate Editor 12.02.19

    • MIS/Robotics | Packaging & Sterilization
      Anxious Undertones: A Review of 2019

      Anxious Undertones: A Review of 2019

      Despite a healthy U.S. economy and solid corporate growth, the medtech industry was wracked with worries in 2019.
      Michael Barbella, Managing Editor 12.02.19


    • Biocompatibility & Testing
      Automated Analysis Advantages for Part Validation

      Automated Analysis Advantages for Part Validation

      Accomplishing part fabrication validation can be better facilitated through the incorporation of automated protocols.
      Edward Jaeck, Vice President of Strategic Growth and Business Development, Lowell Inc. 09.17.19

    • Machining & Tooling
      Tried and True Metalworking

      Tried and True Metalworking

      While device manufacturers are curious about newer parts fabrication technologies, they still rely heavily on traditional machining providers.
      Mark Crawford, Contributing Writer 09.17.19

    • Spine/Neurology
      Back in the Game: A Look at Spine Innovations

      Back in the Game: A Look at Spine Innovations

      An examination of truly unique technologies impacting the spinal sector.
      Michael Barbella, Managing Editor 09.17.19


    • Biologics | Bracing/Prosthetics | Extremities | Imaging | Instruments | Large Joint | MIS/Robotics | Spine/Neurology | Trauma/Sports
      The 2019 Top 10 Global Orthopedic Device Firms

      The 2019 Top 10 Global Orthopedic Device Firms

      Robotics and M&A continued to define the orthopedics industry in 2018.
      ODT Staff 08.14.19

    • Coatings/Surface Modification
      Supporting the Surface: A Look at a New Orthopedic Coating Technology

      Supporting the Surface: A Look at a New Orthopedic Coating Technology

      A novel ortho-coating could improve joint replacement outcomes.
      Vicki A. Barbur, Ph.D. and Anthony Duong, Ph.D., Battelle 08.14.19

    • Design | Research & Development
      Designing Complexity Simply

      Designing Complexity Simply

      New technologies and techniques allow orthopedic device developers to more effectively create advanced products.
      Mark Crawford, Contributing Writer 08.14.19


    • Bracing/Prosthetics | Imaging | Large Joint | Trauma/Sports
      Hidden Gems: 6 Orthopedic Technology Innovators of Note

      Hidden Gems: 6 Orthopedic Technology Innovators of Note

      These organizations are offering intriguing technologies to improve orthopedic care and, as such, have piqued the ODT editors’ interests.
      Sam Brusco, Sean Fenske, and Michael Barbella 08.14.19

    • Biologics
      The ABCs of HCT/Ps

      The ABCs of HCT/Ps

      Navigating the complex regulatory pathway of human cell and tissue products.
      Lindsay Kleinwaks, Ph.D., Associate, Regulatory Affairs, MCRA 05.23.19

    • Coatings/Surface Modification | Materials
      Face Value: An Overview of Surface Modification and Coatings

      Face Value: An Overview of Surface Modification and Coatings

      Orthopedic and spinal device surface treatments are necessary for a variety of aesthetic and functional improvements.
      Sam Brusco, Associate Editor 05.23.19

    • 3-D Printing/Additive Mfg. | Biologics | Extremities | Materials
      A Little Extreme: Factors Impacting the Extremities Implants Segment

      A Little Extreme: Factors Impacting the Extremities Implants Segment

      3D printing, surgical planning, and innovations that simplify procedures increasingly are shaping the global extremities market.
      Michael Barbella, Managing Editor 05.23.19

    • 3-D Printing/Additive Mfg. | Coatings/Surface Modification | Contract Manufacturing | Extremities | Finishing | Large Joint | Laser Processing | Machining & Tooling | Materials | Spine/Neurology
      Technology Revision: Changes in Implant Manufacturing

      Technology Revision: Changes in Implant Manufacturing

      Aspects of implant manufacturing are changing, enabling improved fabrication techniques with new material options.
      Mark Crawford, Contributing Writer 05.23.19

    • 3-D Printing/Additive Mfg. | Design | Prototyping
      Additive Manufacturing: A Tool for Driving Innovation

      Additive Manufacturing: A Tool for Driving Innovation

      Production applications for additive manufacturing are growing, but there are considerations to keep in mind.
      Tom Fripp, Founder and Managing Director, Addition Design & Research 03.29.19


    Breaking News
    • Orthofix Appoints New Spine Business Leader
    • Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    • Synaptive Medical's Modus V Expands Into Spine Market
    • 3D-Printed Graftless Bone Transplants Go to Clinical Trials
    • CrossRoads Extremity Systems Acquires Implant Systems from Surgical Frontiers
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • From Nitinol to Nanotubes: A Materials Science Roundtable
    • In Good Repair: Trauma Technologies Under Review
    • Anxious Undertones: A Review of 2019
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    Coatings World

    Latest Breaking News From Coatings World

    Cristo Rey High School Educator Named 2019 Axalta All-Pro Teacher of the Year
    Michelman Makes United Way of Greater Cincinnati’s List of Top 25 Corporate Campaigns
    BCF: Coatings Industry Reports Record Improvement in Waste, Recycling, Accident Rates
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Roche's Nasal Swab MRSA Test
    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    Eye Test for Parkinson's Gains Breakthrough Designation
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Almac Awarded $1M BMGF Grant
    Vivera Pharma, Parexel Ink Clinical Services Agreement
    MedPharm Triples Capacity at RTP Site
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    WWP Wins Three NJPEC Awards
    Cat-Themed Beauty Collection to Launch in Japan
    Pantone Names Classic Blue the 2020 Color of the Year
    Happi

    Latest Breaking News From Happi

    Lip Lab Opening in Brooklyn
    Raining Rose Expands Exec Team
    Scott’s Sells Personal Care Production Site
    Ink World

    Latest Breaking News From Ink World

    ePac Flexible Packaging Expands into Asia Pacific Market
    Haney, HP Developing Sustainable Fashion Packaging for Heron Preston
    Addipel Moves to New HQ, Expands Production Facility
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    HP teams with Haney for sustainable packaging
    Tags & Labels Printing adds Heidelberg’s Versafire EP
    Austrian converter installs first Nilpeter press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Thrace to Relocate U.S. Capacity
    FiltXPO Speaker Line-Up Announced
    Nölken Incorporates Sustainable Wipes Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Appoints New Spine Business Leader
    Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    Synaptive Medical's Modus V Expands Into Spine Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    IDTechEx Show! Announces Graphene Award Winner
    OE-A Continues to Bring Future of Printed Electronics to CES 2020
    Avancis, Smit Thermal, HZB, CNRS, Solliace Team for Higher Efficiencies in CIGS

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.